Purdue Pharma signs guilty plea, preps $8B+ settlement on Oxy controversy — report; Flagship brings in a comms chief
Purdue Pharma may soon be signing off on a guilty plea and an $8 billion-plus settlement to wrap up its controversial role distributing OxyContin. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
